Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.


Journal

Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 26 03 2018
accepted: 04 09 2018
pubmed: 14 9 2018
medline: 18 12 2019
entrez: 14 9 2018
Statut: ppublish

Résumé

The therapeutic options in the treatment of cancer therapy have been recently significantly increased with systemic immune-targeted therapies. Novel immunotherapy approaches based on immune checkpoint blockade or engineered cytotoxic T lymphocytes have reached late-stage clinical development, with highly encouraging results. The success of cancer immunotherapy has generated a tremendous interest in further developing and exploring these strategies in combination with other approaches such as radiotherapy and local ablative therapies in oncology. The goal of this review is to discuss current approaches in immunotherapy and provide simple and constructive explanations on their mechanisms of action as well as certain more common and serious toxicities.

Identifiants

pubmed: 30209564
doi: 10.1007/s00270-018-2074-1
pii: 10.1007/s00270-018-2074-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1221-1229

Auteurs

A Digklia (A)

Department of Oncology, CHUV, Lausanne, 1011, Switzerland. antonia.digklia@chuv.ch.

R Duran (R)

Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
University of Lausanne, Lausanne, Switzerland.

K Homicsko (K)

Department of Oncology, CHUV, Lausanne, 1011, Switzerland.

L E Kandalaft (LE)

Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

A Hocquelet (A)

Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
University of Lausanne, Lausanne, Switzerland.

A Orcurto (A)

Department of Oncology, CHUV, Lausanne, 1011, Switzerland.

G Coukos (G)

Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

A Denys (A)

Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH